Bank of England signals further easing after rate cut, slashes growth outlook
Read more at CNBC
Topics
-
Bank of England halves growth forecast and cuts rates to 4.5%
Revised economic estimates represent blow to Labour but buoy stock market and giltsFinancial Times - 40m -
Bank of England cuts interest rates to 4.5%
The Bank of England has announced an interest rate cut to 4.5%. CBS News foreign correspondent Ramy Inocencio has more on what that means.CBS News - 1h -
Bank of England cuts interest rates to 4.5% and halves UK growth forecast
Latest quarter-point reduction comes with warning households face inflation of 3.7% by autumn. Unambiguously bleak forecasts pave way for spending cuts What does the rate cut mean for ...The Guardian - 3h -
Bank of England expects to cut borrowing costs further after rate cut today – business live
UK central bank cuts interest rates, and warns growth will be half as fast as expected this year, sending pound sliding. Bank of England cuts interest rates to 4.5% but halves UK growth ...The Guardian - 2h -
Bank of England expected to cut key UK interest rate to 4.50%
The Bank of England is widely expected to cut interest rates for the third time in six months later Thursday even though inflation remains above its targetABC News - 8h -
Bank of England to resume rate cuts with outlook complicated by tax hikes and Trump tariffs
Traders have ramped up their bets on the total number of BOE rate cuts in 2025 since January, as Europe diverges from the U.S.CNBC - 1d -
Bank of England expected to cut rates again as UK economy stagnates
Quarter-point reduction forecast even as short-term inflation pressures are set to increaseFinancial Times - 3d -
European Central Bank Cuts Interest Rates as Economic Growth Stagnates
The European Central Bank’s reduction, the fifth consecutive cut since last summer, came a day after the U.S. Federal Reserve held interest rates.The New York Times - 6d -
UK economy's disappointing November growth fuels the case for Bank of England rate cut
The U.K. economy grew at a lackluster pace of 0.1% in November, data from the Office of National Statistics showed Thursday.CNBC - Jan. 16
More from CNBC
-
How Calvin Klein and Tommy Hilfiger got caught in Trump's trade war with China
The owner of Calvin Klein and Tommy Hilfger has been placed on China's unreliable entities list, which could force it to cease operations in the region.CNBC - 2h -
Amazon set to pass Walmart in revenue for first time
Analysts surveyed by LSEG are expecting Amazon to report revenue of $187 billion for its latest quarter on Thursday.CNBC - 2h -
Trump's tax cuts are 'stuck in the mud' as Republicans split over spending
Fiscal hawks are demanding deeper cuts on major tax, energy and healthcare package that would advance key Trump administration priorities.CNBC - 2h -
Roblox plummets 16% on disappointing bookings, daily active users miss
Roblox shares plunged more than 16% after falling short of Wall Street's bookings and daily active user estimates.CNBC - 18m -
Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short
Zepbound and Mounjaro have now underperformed expectations for two straight quarters.CNBC - 1h
More in Business
-
Treasury Sought to Freeze Foreign Aid Payments, Emails Show
Trump administration appointees and allies of Elon Musk wanted to use the Treasury’s sensitive payment system to block payments.The New York Times - 6m -
Oil prices look to bounce off 2025 lows after Saudi price hike for Asian buyers
Oil found some support Thursday from an increase in Saudi Arabia’s crude prices for Asian buyers, which implied strength in crude demand. But a hefty rise in last week’s U.S. supplies and ...MarketWatch - 8m -
Roblox plummets 16% on disappointing bookings, daily active users miss
Roblox shares plunged more than 16% after falling short of Wall Street's bookings and daily active user estimates.CNBC - 18m -
Lilly’s Mounjaro and Zepbound contribute to big revenue boost, drugmaker says
Eli Lilly has “tremendous momentum” entering 2025, CEO David A. Ricks said Thursday.MarketWatch - 19m -
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.CNBC - 19m